Tumour necrosis factor inhibitors in Ulcerative colitis: real-world data on Therapeutic drug monitoring and evaluation of current treatment targets (STRIDE II).

Ann Med · 2025 · PMC11721610 · PMID 39757985

Europe PMC DOI

hedged sentence

0.8000

closest p · 16.0× alpha

0.8000

boldest claim

The sentences

did not reach statistical significancep = 0.8not close (p > 0.1)

The difference in achievement of target drug levels between TNFi did not reach statistical significance at three ( p = 0.8) or twelve ( p = 0.08) months.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.